26.03 - Ndays 2025 _ Brochure_Clinical_Cases - Flipbook - Page 12
CLINICAL CASE
Bio-regeneration:
safety in complex
biology
Dr Francesco Marchetti
Plastic Reconstructive and Aesthetic Surgeon,
Italy
REPORT SUMMARY
PATIENT
A 54-year-old woman (Fitzpatrick III) with
superficial fat deflation and poor skin
elasticity had shown limited improvement
after several high-volume BDDE-HA
treatments.
TREATMENTS
Switching to Neauvia Stimulate (PEGHA 26 mg/ml with CaHA) resulted in
clear redefinition of fat compartments,
improved skin quality, and long-lasting
effects.
BEFORE
RESULTS
The treatment proved more effective,
with excellent biointegration and
a high safety profile in Hashimoto
patients, thanks to the absence of
inflammatory responses. By stimulating
fibroblasts and collagen I/III production,
Neauvia Stimulate promoted true
bioregeneration, even in delicate,
autoimmune-compromised skin.
AFTER
FILLERS
STIMULATE
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to
applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results
shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently
based on numerous factors. Outcomes are variable and not guaranteed.
10
